Therapeutic effect of hyperbaric oxygen on inclusion body myositis

Max Pell, Poovendran Saththasivam, Peter L. Stephens, George Mychaskiw

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

An inflammatory myopathy, inclusion body myositis (IBM) presents with progressive muscle weakness against a background of elevated creatine kinase and diffuse endomysial damage. Typically occurring in patients greater than 50 years of age, it is commonly misdiagnosed as polymyositis or other rheumatological disease and is often ineffectively treated with steroids [1]. The approach to IBM is frequently a clinical challenge due to its unique and often aberrant response to common treatment modalities. Here we report an apparent improvement in the clinical course of and associated laboratory findings in a patient with co-existing IBM following the use of hyperbaric oxygen therapy as an adjunct for managing ischemic colitis.

Original languageEnglish (US)
Pages (from-to)1111-1114
Number of pages4
JournalUndersea and Hyperbaric Medicine
Volume39
Issue number6
StatePublished - Nov 1 2012

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine
  • Physiology (medical)

Fingerprint

Dive into the research topics of 'Therapeutic effect of hyperbaric oxygen on inclusion body myositis'. Together they form a unique fingerprint.

Cite this